Home LiteratureArticle Details
PMID: 2574622 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.

Brain research ·Vol. 504 ·No. 2 ·1989-12-18 ·Pages 276-83

Bordi F, Meller E

Abstract

Five components of behavior elicited by dopamine (DA) agonists (locomotor hyperactivity, sniffing, oral activity, grooming and paw nibbling) were evaluated after bilateral infusion of the selective D1 agonist fenoldopam (SKF 82526; 2.5-10 micrograms), the selective D2 agonist quinpirole (LY 171555; 5-40 micrograms) and the muscarinic cholinergic antagonist scopolamine (5-20 micrograms) into the ventral striatum of awake, unrestrained rats. Simultaneous bilateral infusion of various dose combinations of fenoldopam (2.5-10 micrograms) and quinpirole (5-20 micrograms) elicited dramatic increases in stereotyped behaviors relative to the effects produced by corresponding doses of each drug alone. Stereotyped sniffing and paw nibbling (self-directed oral activity) were markedly enhanced, whereas conventional oral behaviors (licking, chewing and/or biting) were either slightly or not at all increased. These potentiated responses were reduced or blocked by concomitant infusion of either the selective D1 antagonist SCH 23390 (1 and 5 micrograms) or the selective D2 antagonist sulpiride (0.15 microgram). Scopolamine (10 micrograms) only slightly increased the effects of quinpirole (5 micrograms) on both sniffing and oral behaviors, whereas it dramatically potentiated the effects of fenoldopam (2.5 micrograms) on oral activity; sniffing was only slightly increased. The effects of both drug combinations were almost completely antagonized by infusion of either SCH 23390 (1 microgram) or sulpiride (0.1 microgram). The results demonstrate that the synergistic effects of co-activation of D1 and D2 receptors observed after systemic administration are mediated at least in part by an interaction at the level of the striatum. Differences and similarities between the behaviors expressed after various treatments are discussed.

MeSH Terms
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives,pharmacology Animals Cholinergic Fibers/drug effects,metabolism,physiology Corpus Striatum/drug effects,metabolism,physiology Drug Combinations Ergolines/pharmacology Fenoldopam Male Microinjections Quinpirole Rats Rats, Inbred Strains Receptors, Dopamine/drug effects,physiology Scopolamine/pharmacology Stereotyped Behavior/drug effects
Chemicals
Drug Combinations Ergolines Receptors, Dopamine Quinpirole 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine Scopolamine Fenoldopam
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bordi F
Millhauser Laboratories, Department of Psychiatry, New York University Medical Center, NY 10016.
Meller E
Article Info
Journal
Brain research
Abbr.
Brain Res
ISSN
0006-8993
Published
1989-12-18
Pages
276-83
Language
English
Region
Netherlands
NLM ID
0045503
Subset
IM
Grants
NINDS NIH HHS · NS 22589 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com